Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, clear cell sarcoma, connective tissue neoplasm, dedifferentiated chondrosarcoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sarcoma	Active, not recruiting	Phase 2	2026-07-31		NCT04458922

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana-Farber Cancer Institute	Boston	United States	626
Emory University Hospital Midtown	Atlanta	United States	246
Emory University Hospital/Winship Cancer Institute	Atlanta	United States	299
National Cancer Institute Developmental Therapeutics Clinic	Bethesda	United States	28
National Institutes of Health Clinical Center	Bethesda	United States	800
NCI - Center for Cancer Research	Bethesda	United States	13
Ohio State University Comprehensive Cancer Center	Columbus	United States	548
Siteman Cancer Center-South County	St Louis	United States	222
UF Health Cancer Institute - Gainesville	Gainesville	United States	153
University Health Network-Princess Margaret Hospital	Toronto	Canada	88
UPMC Hillman Cancer Center	Pittsburgh	United States	330
USC / Norris Comprehensive Cancer Center	Los Angeles	United States	249
UT MD Anderson Cancer Center	Houston	United States	204
Vanderbilt University/Ingram Cancer Center	Nashville	United States	259
Washington University School of Medicine	St Louis	United States	895